Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: HK Medical Technologies' Autocath 100

This article was originally published in The Gray Sheet

Executive Summary

HK Medical Technologies' Autocath 100: San Antonio firm obtains investigational device approval to begin enrollment of the first 60 patients in a long-term pivotal trial of its self-contained intraurethral bladder control device for treatment of female stress urinary incontinence. The approved protocol calls for treatment over two six-month periods. The silver-coated stainless steel Autocath is inserted by a physician and is anchored internally in the bladder as well as externally by a lower retention ring. Available in Europe since March 1997, the device is activated when an individual applies over a two-to-four second period abdominal pressure; the device closes when urine flow ends...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel